SNC THERAPEUTICS, INC. — Department of the Interior STTR Phase II: ARPA-H SNC SHIELD
SNC THERAPEUTICS, INC. — STTR Phase II award from Department of the Interior.
Phase II STTR prototype / development signal
- Phase II is where Department of the Interior funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- At $3,498,387, this is a large obligation for typical SBIR Phase sizing — worth reviewing for scope breadth and teaming opportunity.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
SNC Therapeutics received a $3.5 million STTR Phase II award through the Department of the Interior to advance the ARPA-H SNC SHIELD project. The funding helps this small business develop new therapeutic technologies for health-related applications.
- Amount
- $3,498,387
- Agency
- Department of the Interior · Departmental Offices
- Program / Phase
- STTR · Phase II
- NAICS
- 541713 · RESEARCH AND DEVELOPMENT IN NANOTECHNOLOGY
- Place of performance
- IL
- Period
- 2026-09-24 → 2028-09-27
Technology domains
Description
ARPA-H SNC SHIELD STTR PHASE II